BrightSpring Health Services, Inc. (NASDAQ:BTSG) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) have received an average rating of “Moderate Buy” from the fifteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $18.65.

Several equities research analysts recently weighed in on the stock. KeyCorp started coverage on shares of BrightSpring Health Services in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. Mizuho upped their target price on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. BTIG Research lifted their price target on BrightSpring Health Services from $15.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Morgan Stanley upped their price objective on BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. Finally, Wells Fargo & Company lifted their target price on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th.

Institutional Investors Weigh In On BrightSpring Health Services

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Virtu Financial LLC purchased a new position in shares of BrightSpring Health Services during the third quarter worth approximately $522,000. Geode Capital Management LLC grew its stake in BrightSpring Health Services by 0.6% in the third quarter. Geode Capital Management LLC now owns 1,304,214 shares of the company’s stock worth $19,150,000 after purchasing an additional 7,750 shares in the last quarter. Barclays PLC increased its holdings in BrightSpring Health Services by 22.2% during the 3rd quarter. Barclays PLC now owns 393,725 shares of the company’s stock worth $5,780,000 after purchasing an additional 71,633 shares during the period. State Street Corp raised its position in BrightSpring Health Services by 7.4% during the 3rd quarter. State Street Corp now owns 1,239,628 shares of the company’s stock valued at $18,198,000 after purchasing an additional 85,464 shares in the last quarter. Finally, Verition Fund Management LLC lifted its holdings in shares of BrightSpring Health Services by 34.2% in the 3rd quarter. Verition Fund Management LLC now owns 132,918 shares of the company’s stock worth $1,951,000 after buying an additional 33,890 shares during the period.

BrightSpring Health Services Stock Up 1.3 %

Shares of BTSG stock opened at $17.27 on Monday. The company’s fifty day simple moving average is $17.76 and its two-hundred day simple moving average is $14.31. BrightSpring Health Services has a 52 week low of $7.85 and a 52 week high of $20.25. The stock has a market cap of $3.01 billion and a P/E ratio of -66.42. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63.

BrightSpring Health Services (NASDAQ:BTSG) last posted its earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). The firm had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.72 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The company’s quarterly revenue was up 28.8% compared to the same quarter last year. Analysts predict that BrightSpring Health Services will post 0.59 EPS for the current fiscal year.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.